Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan-Jun;25(1):35-40.
doi: 10.4103/0972-6748.196045.

Prevalence of comorbid anxiety disorders in schizophrenia

Affiliations

Prevalence of comorbid anxiety disorders in schizophrenia

Chandra Kiran et al. Ind Psychiatry J. 2016 Jan-Jun.

Abstract

Background: Diagnostic and treatment hierarchical reductionisms have resulted in an oversight of anxiety syndromes in schizophrenia.

Aim: The aim of this study was to find the prevalence of different anxiety disorders in schizophrenia patients.

Materials and methods: The study was conducted on inpatients of a tertiary care psychiatric hospital using a prospective, purposive sampling technique. The study consisted of 93 schizophrenia patients and a similar number of normal controls. The schizophrenia patients and controls were evaluated for psychopathology and the presence of anxiety disorder.

Results: The prevalence of anxiety disorder was significantly higher in schizophrenia patients (45.16%) compared to controls (16.12%). Further, the prevalence of panic disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD) was significantly higher in schizophrenia patients. No significant correlation was observed between anxiety disorder scores and psychopathology scores.

Conclusions: The prevalence of comorbid anxiety disorders (panic disorder, social anxiety disorder, and OCD) in schizophrenia is significantly higher in the general population. The onset of anxiety disorder commonly precedes the onset of schizophrenia.

Keywords: Comorbid anxiety disorders; obsessive-compulsive disorder; panic disorder; schizophrenia; social anxiety disorder.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

Cited by

References

    1. Loga S, Loga-Zec S. Comorbidity in psychiatry: Its impact on psychopharmacological treatment. Psychiatr Danub. 2009;21:347–9. - PubMed
    1. Chaudhury S, Tikka SK, Bakhla AK. Impact of substance use disorder on presentation of schizophrenia. Dual Diagn. 2016;1:7.
    1. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000;26:105–18. - PubMed
    1. Gray JA, Feldon J, Rawlings JN, Hemsley DR, Smith AD. The neuropsychology of schizophrenia. Behav Brain Sci. 1991;14:1–20.
    1. Bleuler E. In: Dementia praecox or the group of schizophrenias. Zinkin J, translator. New York: International Univesities Press; 1950.